Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy

por Takatsu, Noritaka, Hisabe, Takashi, Higashi, Daijiro, Ueki, Toshiharu, Matsui, Toshiyuki
Publicado 2020

Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan

por Ueno, Fumiaki, Matsui, Toshiyuki, Matsumoto, Takayuki, Matsuoka, Katsuyoshi, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2012

134. KRP-A218, an Orally Active and Selective PI4KB Inhibitor with Broad-Spectrum Anti-Rhinovirus Activity, Has Potent Therapeutic Antiviral Activity In vivo

por Matsui, Toshiyuki, Fujita, Motomichi, Ishibashi, Yuji, Nomanbhoy, Tyzoon, Rosenblum, Jonathan S, Nagasawa, Michiaki
Publicado 2021

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease

por Ogata, Haruhiko, Watanabe, Mamoru, Matsui, Toshiyuki, Hase, Hidenori, Okayasu, Motohiro, Tsuchiya, Tsuyoshi, Shinmura, Yasuhiko, Hibi, Toshifumi
Publicado 2016

The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management

por Hibi, Toshifumi, Panaccione, Remo, Katafuchi, Miiko, Yokoyama, Kaoru, Watanabe, Kenji, Matsui, Toshiyuki, Matsumoto, Takayuki, Travis, Simon, Suzuki, Yasuo
Publicado 2017

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study

por Hisamatsu, Tadakazu, Suzuki, Yasuo, Kobayashi, Mariko, Hagiwara, Takashi, Kawaberi, Takeshi, Ogata, Haruhiko, Matsui, Toshiyuki, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2021

Long-Term Outcome of Endoscopic Balloon Dilation in Obstructive Gastrointestinal Crohn's Disease: A Prospective Long-Term Study

por Matsui, Toshiyuki, Ikeda, Keisuke, Tsuda, Sumio, Yao, Kenshi, Sou, Suketo, Satoh, Shigeru, Hatakeyama, Sadamune, Matake, Hiroaki, Sakurai, Toshihiro, Yao, Tsuneyoshi
Publicado 2000

Validity of the usefulness of microvascular architecture and microsurface structure using magnifying endoscopy with narrow-band imaging in the colorectal neoplasm

por Hisabe, Takashi, Yao, Kenshi, Beppu, Takahiro, Ninomiya, Kazeo, Nagahama, Takashi, Takaki, Yasuhiro, Hirai, Fumihito, Matsui, Toshiyuki, Tanabe, Hiroshi, Iwashita, Akinori
Publicado 2013

Characterization of gut microbiota profiles by disease activity in patients with Crohn’s disease using data mining analysis of terminal restriction fragment length polymorphisms

por ANDOH, AKIRA, KOBAYASHI, TOSHIO, KUZUOKA, HIROYUKI, TSUJIKAWA, TOMOYUKI, SUZUKI, YASUO, HIRAI, FUMIHITO, MATSUI, TOSHIYUKI, NAKAMURA, SHIRO, MATSUMOTO, TAKAYUKI, FUJIYAMA, YOSHIHIDE
Publicado 2014

Two patients with new granulomatous lung lesions during treatment of Crohn's disease

por Takeda, Satoshi, Akagi, Takanori, Miyazaki, Hiroyuki, Kodama, Masaru, Yamamoto, Satoshi, Beppu, Takahiro, Nagahama, Takashi, Matsui, Toshiyuki, Watanabe, Kentaro, Nagata, Nobuhiko
Publicado 2014

Validity of conventional endoscopy using “non-extension sign” for optical diagnosis of colorectal deep submucosal invasive cancer

por Hisabe, Takashi, Tsuda, Sumio, Hoashi, Toshio, Ishihara, Hiroshi, Yamasaki, Kazutomo, Yasaka, Tatsuhisa, Hirai, Fumihito, Matsui, Toshiyuki, Yao, Kenshi, Tanabe, Hiroshi, Iwashita, Akinori
Publicado 2018

Possible Earlier Diagnosis of Ulcerative Colitis-Associated Neoplasia: A Retrospective Analysis of Interval Cases during Surveillance

por Hisabe, Takashi, Matsui, Toshiyuki, Yamasaki, Kazutomo, Morokuma, Tsuyoshi, Aomi, Kenmei, Yoshizawa, Naoyuki, Takatsu, Noritaka, Yao, Kenshi, Ueki, Toshiharu, Futami, Kitaro, Tanabe, Hiroshi, Iwashita, Akinori
Publicado 2021

Effectiveness of Concomitant Enteral Nutrition Therapy and Infliximab for Maintenance Treatment of Crohn’s Disease in Adults

por Hirai, Fumihito, Ishihara, Hiroshi, Yada, Shinichirou, Esaki, Motohiro, Ohwan, Tomohisa, Nozaki, Ryoichi, Ashizuka, Shinya, Inatsu, Haruhiko, Ohi, Hidehisa, Aoyagi, Kunihiko, Mizuta, Yohei, Matsumoto, Takayuki, Matsui, Toshiyuki
Publicado 2012

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

por Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2019

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

por Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2019

Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

por Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Publicado 2019

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis

por Naganuma, Makoto, Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Matsui, Toshiyuki, Suzuki, Yasuo, Ursos, Lyann, Sakamoto, Shigeru, Shikamura, Mitsuhiro, Hori, Tetsuharu, Fernandez, Jovelle, Watanabe, Mamoru, Hibi, Toshifumi, Kanai, Takanori
Publicado 2021

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

por Komoto, Shunsuke, Motoya, Satoshi, Nishiwaki, Yuji, Matsui, Toshiyuki, Kunisaki, Reiko, Matsuoka, Katsuyoshi, Yoshimura, Naoki, Kagaya, Takashi, Naganuma, Makoto, Hida, Nobuyuki, Watanabe, Mamoru, Hibi, Toshifumi, Suzuki, Yasuo, Miura, Soichiro, Hokari, Ryota
Publicado 2016

Effect of a concomitant elemental diet with maintenance anti‐tumor necrosis factor‐α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study

por Hirai, Fumihito, Ishida, Tetsuya, Takeshima, Fuminao, Yamamoto, Shojiro, Yoshikawa, Ichiro, Ashizuka, Shinya, Inatsu, Haruhiko, Mitsuyama, Keiichi, Sou, Suketo, Iwakiri, Ryuichi, Nozaki, Ryoichi, Ohi, Hidehisa, Esaki, Motohiro, Iida, Mitsuo, Matsui, Toshiyuki
Publicado 2018

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study

por Koga, Akihiro, Matsui, Toshiyuki, Takatsu, Noritaka, Takada, Yasumichi, Kishi, Masahiro, Yano, Yutaka, Beppu, Takahiro, Ono, Yoichiro, Ninomiya, Kazeo, Hirai, Fumihito, Nagahama, Takashi, Hisabe, Takashi, Takaki, Yasuhiro, Yao, Kenshi, Imaeda, Hirotsugu, Andoh, Akira
Publicado 2018